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Background: Resilience is proven as a protective factor against the development
of psychiatric disorders, and it has gained clinical relevance in the development and
progression of cardiovascular pathology. The authors performed a longitudinal study on
patients with implantable cardioverter defibrillator (ICD) with the primary aim to highlight
the possible existence of a correlation between individual resilience capacity, depressive
and anxiety symptoms, and quality of life in terms of outcomes. The secondary aim was
to analyze the differences between patients with major cardiac events in the follow-up
and patients without cardiac events with respect to the previous variables.
Materials and Methods: A total of 80 patients enrolled in the Cardiology Unit were
evaluated at T0 and during the follow-up through the following scales: the 14-item
Resilience Scale (RS-14), the Hospital Anxiety and Depression Scale (HADS), and the
World Health Organization Quality of Life-Brief Version (WHOQOL-Bref).
Results: A significant linear correlation between resilience and all the areas of quality
of life at T0, T1, and T2 emerged. A negative correlation between resilience and anxiety
and depressive symptoms emerged, as well as between depression and anxiety and
quality of life. Patients with cardiac events during the follow up have shown a worse
quality of life and the onset of anxiety-depressive symptoms over time, without changes
to the resilience scores. Patients without cardiac events showed an increasing trend in
resilience scores.
Discussion: Given the speed and simplicity of use of the RS-14 scale, it seems
promising to further investigate the real clinical usefulness of this instrument in the
cardiology field.
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BACKGROUND
In recent years, resilience, defined as the “universal capacity
which allows a person, group or community to prevent, minimize
or overcome the damaging effects of adversity” (1), has gained
clinical relevance in several medical disciplines, with particular
attention to development and progression of chronic diseases.
In fact, resilience not only moderates the link between risk
factors and outcome but also allows maximizing the benefits
coming from specific interventions, aimed at recovering from
specific pathologies (2, 3). Indeed, resilience has proved itself
effective in allowing a more rapid remission, increasing coping
skills regarding one’s condition and related treatments; this is
also in line with current neuroscientific models (4–6). Regarding
cardiovascular pathology, resilience is found to be particularly
high in patients with coronary artery disease (7), although
lower than the general population (8), and is associated with
a better outcome (9) and a minor incidence of post-traumatic
stress disorder symptoms (10). Some authors (5, 11) found that
in cardiovascular population, psychological resilience seems to
independently predict patients’ mental and physical quality of
life but has not been examined in relation to depression and in
relation to the use of implantable cardioverter defibrillator (ICD).
Most patients undergoing ICD placement are able, within a
span of variable time after the surgery, to recover their normal
level of activity (12) with a good degree of satisfaction with
the device (13). However, a significant percentage of patients
could experience more relevant difficulties, which may persist
for a prolonged time. The reported prevalence of common
psychological and emotional disorders among carriers of ICD
ranges from 15 to 60% (14, 15). The most represented diagnoses
are anxiety disorders (24–87%), depressive disorders (9–15%),
post-traumatic stress disorder (up to 20%), and adjustment
disorders (16, 17).
The link between resilience and depressive symptoms is
also well-known; several studies concluded that resilience is
a protective factor against the development of psychiatric
disorders, such as PTSD and depression (18, 19). Furthermore,
negative effects and their reciprocal influences with resilience
have been related to an increased risk of mortality in
patients with cardiovascular disease (20, 21). In fact, there
is an intrinsic relationship between psychological state and
arrhythmic risk, demonstrated by the increased incidence of
ventricular arrhythmias malignant in subjects with anxiety and
depression (11).
Moreover, the psychological sequelae, experienced by ICD
patients, may cause an impairment of their quality of life. The
perception of a good quality of life in ICD carriers, defined
as “a multidimensional health outcome in which biological,
psychological and social functioning are interdependent,” should
be taken into consideration as a success factor for the
implant (22).
Given this premise, the authors performed a longitudinal
study on 80 patients with ICD with the primary aim to highlight
the possible existence of a correlation between individual
resilience capacity and depressive and anxiety symptoms, using
quality of life in terms of outcomes. The secondary aim was
to analyze the differences between patients with major cardiac
events (death, hospitalizations, incidence of arrhythmias, and
ICD shocks) in the follow-up and patients without cardiac events
with respect to the previous variables.
MATERIALS AND METHODS
The prospective observational study VC was conducted on 80
patients enrolled in the Cardiology Unit of the “ASST Sette
Laghi—Ospedale di Circolo—Fondazione Macchi” of Varese.
The study was approved by the Ethical Committee of Insubria on
April 10, 2018 (study no. 22). This study observed regulatory and
legal requirements (DL n.211, June 24, 2003, and DM December
17, 2004), according to the Declaration of Helsinki’s ethical
principles. Following the Institutional Review Board approval,
all patients were specifically informed about the opportunity to
participate in this study and signed a written specific consent
before the enrollment. Data collected referred to the period
between June 15, 2018 and June 30, 2019. Patients were evaluated
at T0, at the time of ICD implant, after 3 months (T1), and after
12 months (T2).
To be enrolled in the present study, patients had to
fulfill the following inclusion criteria: patients aged between
18 and 85 years with indication to ICD implant, both in
primary and secondary prevention; and willingness to sign the
informed consent. Exclusion criteria were life expectancy <12
months, neurodegenerative diseases, moderate or severe
cognitive impairment, moderate or severe intellectual
disability, depressive and anxiety disorders diagnosis,
previous or current psychopharmacology treatment at T0,
or abuse of alcohol or illicit substances. The following
socio-demographic and clinical variables were taken into
consideration: gender, age, education, marital status,
employment, living conditions, past medical history, length
of hospitalization, type of ICD, New York Heart Association
(NYHA) (23) class, number of shocks after the implant,
hospitalization, and access to the emergency room of
cardiological relevance.
The following evaluation scales were administered at T0 and
during the follow up: the 14-item Resilience Scale, which allows
the assessment of resilience levels according to a two-factor
structure (competence personal and self-acceptance) (24–26); the
Hospital Anxiety and Depression Scale (HADS) that consists of 14
items, 7 of those for anxiety levels, whereas the others estimate
depression grades, and that showed acceptable psychometric
properties in several medical fields including cardiology (27,
28); and the World Health Organization Quality of Life-Brief
Version (WHOQOL-Bref), shortened version of WHOQoL-100,
which comprises four domains (physical health, psychological
health, relationships, and environment) and allows an overall
judgment on patients’ quality of life and on general health
(29, 30).
Collected data were analyzed using SPSS Version 22.0
(IBM Corp., Armonk, NY, 2013). Continuous variables were
represented bymean± deviation standard or median± standard
error in case of non-Gaussian distribution. The qualitative
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Mean 69 ± 10.49
Education
None 1 (1.3%)
Primary school 26 (34.7%)
Junior high school/High school 6 (60%)











No caregiver 69 (92%)
Caregiver 6 (8%)
Familiarity for serious mental illness 0
Past medical history
Hypertension 59 (78.67%)
Previous myocardial ischemia 50 (66.67%)
Respiratory pathologies 19 (25.33%)
Neoplastic pathologies 11 (14.67%)
Neurologic pathologies 12 (16%)
Minor psychiatric disorders 4 (5.33%)
NYHA class T0
Class I 40 (53.33%)
Class II 27 (36%)
Class III 7 (9.33%)
Class IV 1 (1.33%)
variables were represented by frequencies and distributions of
frequency. Once the normal distribution of the scores obtained at
the RS-14 was confirmed, comparison of means by ANOVA test
was performed; given the non-normality of other data (Lilliefors
p <0.05) the Mann-Whitney test was used. The evaluation of the
existence of a possible correlation between resilience and other
continuous variables collected was made through the calculation
of Pearson’s R and R2. Authors also performed a multivariate
regression considering resilience, depression, and anxiety as
independent variables and WHOQOL-Bref scores as dependent
variables. The possible existence of a variation of resilience
and other psychological variables over time was subsequently
assessed, using the ANOVA test for paired data and theWilcoxon
Matched Pairs Test for non-Gaussian data. A p value < 0.05 was
considered statistically significant.
TABLE 2 | Psychological variables at T0, T1 and T2.
T0 T1 T2
RS-14 (mean) 85.52 ± 9.61 88.00 ± 9.40 87.61 ± 5.55
HADS-d (median) 5 ± 0.74 2 ± 0.60 4 ± 0.58
HADS-a (median) 6 ± 0.63 3 ± 0.61 4 ± 0.58
WHOQoL-Bref (mean)
Global 55.25 ± 2.97 50.00 ± 2.76 62.50 ± 2.67
Physical health 66.07 ± 1.40 71.41 ± 1.44 69.65 ± 2.28
Psychological 70.83 ± 1.33 70.83 ± 1.32 70.83 ± 1.41
Social relationship 70.85 ± 1.74 66.67 ± 1.60 66.67 ± 1.70
Environment 65.61 ± 1.90 65.63 ± 1.34 68.75 ± 1.27
RESULTS
Participation in the study was proposed to 80 patients; 75
patients (93.75%) signed the informed consent with subsequent
enrollment. At T1, 7 patients dropped out of the study because
they did not want to be assessed thorough the questionnaires.
At T2, among the 37 patients recruited for this last phase of
study, one patient died not for cardiovascular problems, and
36 completed the follow-up. Socio-demographic and clinical
characteristics of samples are listed in Table 1.
The hospitalization lasted between 3 and 68 days, with
a median of 6 days (95% CI = 8–13 days). Most patients
(89.33%) were discharged at home, whereas 8 patients (10.67%)
were admitted to a cardiological rehabilitation center after
hospital discharge. Implant complications occurred in 5 patients
(6.67%): in two cases the cause was arrhythmic, two were on a
hemorrhagic basis, and one on an infectious basis. The ICD was
implanted in primary prevention in 59 patients (78.67%), while
in the remaining 21.33% (n = 16) in secondary prevention for
sustained ventricular arrhythmias (68.75%; n = 11) or cardio-
circulatory arrest (31.25%; n = 5). Forty patients (53.33%)
received a single/dual chamber defibrillator, 40% (n = 30) a
biventricular defibrillator, whereas the remaining 6.67% (n = 5)
a subcutaneous device. Table 2 shows changes of the considered
psychological variables during the study period (Table 2).
By comparing intra-individual’s modification of RS-14 score
at T0 and during the follow-up, no statistically significant
differences emerged (p= 0.06).
Regarding the HADS scores, anxious symptomatology
improved at the first follow-up after 3 months (p = 0.008),
though it worsened again after 12 months (p = 0.007). On
the contrary, depressive symptoms underwent a progressive
improvement between T0 and T1 (p = 0.002) then remained
stable over time. Regarding the WHOQoL global score, no
statistically significant differences were observed between T0
and T1 (p = 0.37), whereas it has improved at the second
follow-up after 12 months (p = 0.002); no statistically
significant differences were observed in the Physical Health
and Psychological domains’ score over the study period. In the
Social Relationship domain, patients’ scores worsened at the first
follow-up (p = 0.027), showing no further variation after 12
months. Lastly, a statistically significant difference was observed
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Physical health 0.44 <0.0001
Psychological 0.56 <0.0001




in the Environment domain, with a clear improvement after 12
months from the implant (p= 0.03).
A significant linear correlation was found between resilience
(RS-14) and all areas of quality of life (WHOQoL-Bref), except
for the Social Relationship domain, during the whole study
period. In greater detail, this correlation appeared stronger
for Physical Health and Psychological domains (Table 3).
Furthermore, a strong inverse correlation between resilience
levels and anxious-depressive symptoms emerged from data
analysis; these results remained constant over time during the
subsequent follow-up (Table 3).
At the first outpatient visit to check ICD functioning (T1), it
emerged that two patients received a shock from the device; one
patient had been appropriately shocked for the onset of sustained
ventricular tachycardia, whereas for the other the shock was
inappropriate for the onset of atrial fibrillation. By consulting the
hospital software, it was also found that 13.24% of patients had
one or more accesses to the emergency department or admissions
to the cardiology department. In greater detail, 66.67% of the
patients had one access only, whereas the remaining 33.33%
had two or more accesses. The main causes of hospitalization
were arrhythmias (22.22%), heart failure (44.44%), myocardial
infarction (11.11%), and other cardiac causes (22.22%).
At T2, ICD shocks had been recorded for four patients: two
patients received appropriate shocks for the onset of sustained
ventricular tachycardia, whereas one patient received three
inappropriate ICD shocks for the onset of supraventricular
tachycardia. It was also found that 27.03% of patients had made
one or more visits to the emergency room or admissions to
cardiology department. Leading causes of hospitalization were
the presence of arrhythmias (30%) and the onset of heart failure
(30%), followed bymyocardial infarction (20%) and other cardiac
causes (20%).
In the group of patients that concluded the follow-up with
events, an improvement has been observed during the whole
study period in the Psychological, Social Relationship, and
Environment domains, whereas other psychological variables
did not show statistically significant variations. No statistically
significant differences were found in patients without events
(Table 4).
Comparing the group of patients, those with events (device
shocks and/or hospital admissions for cardiac causes) and those
without events, it was found that at time T1 the patients with
cardiac events presented on average increased levels of anxiety
(3 ± 0. 41 vs. 5 ± 1.27; z = −1.90; p = 0.06) and a significant
reduction in the overall quality of life (62.50 ± 2.28 vs. 43.75
± 6.57; z = 2.67; p = 0.008). Similar results were found at
T2: patients with cardiac events had on average a worse overall
quality of life (62.50 ± 3.29 vs. 50.00 ± 4.85; z = 2.79; p =
0.009); furthermore, patients with events show worse scores in
the Environmental domain compared to those without cardiac
events and/or hospitalization (68.75 ± 2.07 vs. 59.37 ± 3.07;
z =−2.99; p= 0.005). No further statistical differences had been
observed in the two groups.
A multivariate regression considering resilience, anxiety,
and depression as independent variables and WHOQOL-Bref
as the dependent one was performed at each time point of
the study.
At T0, an association between the physical (b = 0.45;
p= 0.0001), psychological (b = 0.47 p <0 0001 areas), and
environmental areas (b = 0.30; p = 0.02) of the WHOQOL-
Bref emerged. No independent variables and global and social
quality of life were identified. Anxiety was characterized as
an independent modifier of the physical area (b = −0.28;
p= 0.02) and depression as an independent modifier of the
psychological area (b=−0, 26; p= 0.03). At T1, the multivariate
analysis showed that resilience was independently associated
with the physical areas (b = 0.28; p = 0.019), with the
social one (b = 0.50; p = 0.0001), and the psychological one
(b= 0.48; p < 0.0001) of the WHOQOL-Bref. Anxiety (b =
−0.27; p = 0.016) and depression (b = −0.28; p = 0.04) were
also related to the physical and psychological areas (anxiety:
b = −0.23; p = 0.01; depression: b = −0.28; p = 0.009),
while the environmental area showed a correlation only with
depression (b = −0.40; p = 0.022). At T2, no significant
findings emerged.
DISCUSSION
Despite the success of cardiac defibrillator implantation for the
prevention of sudden cardiac death and in terms of cardiological
outcome, there is a growing demand not only to improve the
general mortality and safety of patients, but also their quality
of life (14). Many patients with ICD experience high degrees of
distress in the period immediately before and after the implant,
but most of them are usually able to quickly return to normal
activities and report feelings of relief. Cardiac events, however,
can worsen the individual response to the implant. The purpose
of this work was therefore to describe the complex interaction
between underlying cardiological disease, ICD implantation, and
individual factors of stress vulnerability and resilience on a real
clinical sample, in order to better understand the psychological
variables on which to intervene in order to obtain a better
adaptation and an increase in the quality of life. In fact, emotion
regulation has emerged as one of the most important personal
competencies in modulating the risk of psychopathological
burden (31, 32). Moreover, as in other clinical fields, better health
outcomes could also be predicted using the pharmacogenetic
information through pharmacogenetic testing as part of routine
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TABLE 4 | Changes in psychological variables in patients without and with events (ICD shocks and/or hospitalization).
T0 T1 T2 T0-T2 p-value
Changes in psychological variables in patients without events
RS-14 (mean) 84.45 ± 11.17 84.73 ± 10.00 86.18 ±5.04 t = 0.59 0.57
HADS-d (median) 3 ± 1.42 3 ± 1.32 4 ±0.82 z = 0.77 0.44
HADS-a (median) 6 ± 1.15 4 ± 1.26 5 ±1.30 z = 0.12 0.91
WHOQoL-Bref (mean)
Global 50.00 ± 4.85 50.00 ± 5.61 50.00 ±5.93 z = 0.84 0.07
Physical health 60.71 ± 4.03 67.86 ± 3.32 64.29 ±4.43 z = 0.46 0.65
Psychological 58.33 ± 4.93 70.80 ± 2.97 70.83 ±2.60 z = 1.94 0.05
Social relationship 66.70 ± 3.05 66.67 ± 2.41 66.67 ±2.19 z = 2.03 0.04
Environment 59.37 ± 3.07 65.63 ± 2.74 68.75 ±2.12 z = 2.52 0.011
Changes in psychological variables in patients with events
RS-14 (mean) 86.00 ± 9.06 89.44 ± 8.97 88.24 ±5.75 t = 1.29 0.21
HADS-d (median) 5 ± 0.87 3 ± 0.65 4 ±0.69 z = 2.28 0.02
HADS-a (median) 6 ± 0.77 2 ± 0.70 4 ±0.62 z = 1.56 0.12
WHOQoL-Bref (mean)
Global 62.50 ± 3.29 62.50 ± 3.06 62.50 ±2.79 z = 1.38 0.17
Physical health 71.43 ± 2.30 71.43 ± 2.14 71.43 ±2.61 z = 0.69 0.49
Psychological 70.80 ± 2.37 75.00 ± 2.49 70.83 ±1.73 z = 0.89 0.37
Social relationship 75.00 ± 2.16 75.36 ± 2.41 76.12 ±2.19 z = 1.99 0.17
Environment 68.75 ± 2.07 65.63 ± 1.48 68.85 ±1.53 z = 1.38 0.16
clinical care in the management of cardiovascular disease (33–
35). In general, it is possible to observe that in the year following
an ICD implant, patients need a period of adaptation, against
which various internal and external factors intervene, with
consequences both on a psychological level and on the quality
of life. After a year an overall improvement was observed in
both aspects; however, for patients who presented problems of
a cardiac nature during the observation period, such recovery
appears more difficult and slower, also in relation to elements of
reinforcement and negative expectations related to body, health,
and future. Patients with cardiac events during the follow-up
have shown a worse quality of life and the onset of anxiety-
depressive symptoms over time, without changes to the resilience
scores. Patients without cardiac events showed an increasing
trend in resilience scores. Good resilience skills can instead
promote faster activation of effective coping strategies, thus
allowing faster remission, as confirmed in other works (4). From
these results, the need to propose an early screening in order
to identify the patients most at risk of developing not only
physical but also psychological complications emerges (36, 37).
The tests used in the present work have proved to be useful in
this regard; in particular, the presence of high levels of resilience,
measured through the RS-14, was found to be statistically
significantly correlated to better perception of life quality and
lower levels of anxiety and depression. This correlation was
maintained both at baseline and in the follow-up. It also showed
no variability in individual scores at either follow-up, thus
confirming it to be an individual characteristic, independent
of external factors. An early definition of the resilience level
of each patient before implantation of a defibrillator could be
a useful tool in predicting the most vulnerable subjects and
therefore guaranteeing the possibility of greater attention to
their psychological well-being and guarantee them a targeted
psychological support path.
Although it is not possible to define a statistically significant
correlation between baseline levels of resilience and the onset
of major cardiac events, due to the limited number of cardiac
events that occurred in the follow-up period, the trend followed
by our data encourages us to continue collecting data on this
topic. Furthermore, given the speed and simplicity of use of
the RS-14 scale, it seems promising to also further investigate
the real clinical usefulness of this instrument in the cardiology
field. The main limitation of this study is the total sample
size. A further limitation is represented by the recruitment
during the cardiological visit coinciding with the implantation
of the ICD; this situation could in fact affect the patient’s
emotional state and represent a confounding factor in the
responses to the questionnaires. Another limit of the study
could be represented by the lack of collection of information
regarding coping strategies, personality traits, and cognitive
styles of the patients enrolled. The strengths of this study are
represented by the perspective-longitudinal structure and by
the double approach, intra-individual and between groups. This
allowed an optimal evaluation over time of the psychophysical
state of the patients. The sample examined also belongs to
the real-world and is strongly representative of the population
receiving a defibrillator implant. The literature shows little data
in this field and our work appears innovative and a source of
desirable future insights. This work confirms the need for a more
careful assessment of the psychological needs and expectations
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of patients who undergo an ICD implant, especially in the
presence of organic complications; it would be desirable to
carry out a screening before implantation to identify the most
vulnerable patients and direct them to a targeted path that may
include professionals dedicated to the treatment of psychological
complications as well as physical ones. Given the speed and
simplicity of use of the RS-14 scale, it seems promising to further
investigate the real clinical usefulness of this instrument in the
cardiology field.
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